Genesis Therapeutics
Burlingame, United States· Est. 2019
At Genesis we’re unlocking tough protein targets to discover new medicines at scale, with the industry’s most advanced molecular AI platform.
Private Company
Total funding raised: $256.1M
About
At Genesis we’re unlocking tough protein targets to discover new medicines at scale, with the industry’s most advanced molecular AI platform.
AI / Machine Learning
Funding History
3Total raised:$256.1M
Series B$200MAug 15, 2023
Series A$52MDec 15, 2020
Seed$4.1MDec 15, 2019